World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
101
Citations
33562
World Ranking
390
National Ranking
180

Medicine

D-Index
100
Citations
33829
World Ranking
8322
National Ranking
4302

Michael D. Miller publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Michael D. Miller sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 316 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Michael D. Miller D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael D. Miller sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 101 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2005 - Fellow of American Physical Society (APS) Citation For insightful contributions to the theoretical description and the interpretation of experimental data of quantum fluid mixtures and mixture films

Overview

Michael D. Miller was affiliated with the United States Military Academy in the United States. Their research primarily focused on medicine, with extensive work in infectious diseases, epidemiology, virology, public health, environmental and occupational health, and general health professions.

Their academic output included significant contributions to HIV/AIDS research and interventions, HIV research and treatment, HIV and its intersection with drug use and sexual risk, HIV/AIDS drug development and treatment, opioid use disorder treatment, sex work and related issues, and substance abuse treatment and outcomes.

Among their recent publications were:

  • Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection, 2020, New England Journal of Medicine

Frequent coauthors collaborating with Michael D. Miller included:

  • Roman Shrestha
  • Colleen Mistler
  • Jeffrey A. Wickersham
  • Frederick L. Altice
  • John Gunstad

The venues where their work was often published included:

  • Drug and Alcohol Dependence
  • UNC Libraries
  • AIDS and Behavior
  • Journal of Community Health
  • The Lancet HIV

Their research had a focus on HIV/AIDS treatment and the impact of substance use on health outcomes. Their notable papers frequently addressed treatment-resistant HIV-1 infections and prevention strategies among vulnerable populations.

Michael D. Miller was recognized by the American Physical Society as a Fellow in 2005 for contributions related to quantum fluid mixtures and mixture films, reflecting a diverse academic background beyond the medical sciences.

Best Publications

  • Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.

    Joel E. Gallant;Schlomo Staszewski;Anton L. Pozniak;Edwin DeJesus

  • Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells

    Daria J. Hazuda;Peter Felock;Marc Witmer;Abigail Wolfe

  • Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines.

    Miller;Krangel

  • Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition.

    Michael D. Miller;Chris M. Farnet;Frederic D. Bushman

  • Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

    Roy T. Steigbigel;David A. Cooper;Princy N. Kumar;Joseph E. Eron

  • Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

    Jeffrey L. Lennox;Edwin DeJesus;Adriano Lazzarin;Richard B. Pollard

  • Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.

    David A. Cooper;Roy T. Steigbigel;Jose M. Gatell;Jurgen K. Rockstroh

  • Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.

    Martin Markowitz;Bach-Yen Nguyen;Eduardo Gotuzzo;Fernando Mendo

  • Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

    Jonathan Z. Li;Roger Paredes;Heather J. Ribaudo;Evguenia S. Svarovskaia

  • A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.

    Daria J. Hazuda;Neville J. Anthony;Robert P. Gomez;Samson M. Jolly

  • Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

    Joseph J Eron;Benjamin Young;David A Cooper;Michael Youle

  • FLOG: A system to select ‘quasi-flexible’ ligands complementary to a receptor of known three-dimensional structure

    Michael D. Miller;Simon K. Kearsley;Dennis J. Underwood;Robert P. Sheridan

  • Traumatic Anterior Atlanto-occipital Dislocation

    Barry Powers;Michael D. Miller;Richard S. Kramer;Salutario Martinez

  • Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques

    Daria J. Hazuda;Steven D. Young;James P. Guare;Neville J. Anthony

  • Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study.

    Robert T Schooley;Peter Ruane;Robert A Myers;Gildon Beall

  • Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil

    Chris Westland;William Delaney;Huiling Yang;Shan-shan Chen

  • Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

    Christine Katlama;Steven G Deeks;Brigitte Autran;Javier Martinez-Picado

  • The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro

    William E. Delaney;Huiling Yang;Christopher E. Westland;Kalyan Das;Kalyan Das

  • In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA.

    Mark A Wainberg;Michael D Miller;Yudong Quan;Horacio Salomon

  • Efficacy of Tenofovir Disoproxil Fumarate in Antiretroviral Therapy-Naive and -Experienced Patients Coinfected with HIV-1 and Hepatitis B Virus

    Gregory J. Dore;David A. Cooper;Anton L. Pozniak;Edwin DeJesus

  • NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

    Stefan Zeuzem;Masashi Mizokami;Stephen Pianko;Alessandra Mangia

Frequent Co-Authors

Hongmei Mo
Hongmei Mo Gilead Sciences (United States)
Daria J. Hazuda
Daria J. Hazuda MSD (United States)
Eric Lawitz
Eric Lawitz The University of Texas at Austin
Elisabetta Bianchi
Elisabetta Bianchi Institut Pasteur
Antonello Pessi
Antonello Pessi Schering-Plough
John G. McHutchison
John G. McHutchison Duke University
John W. Shiver
John W. Shiver United States Military Academy
Joseph P. Vacca
Joseph P. Vacca MSD (United States)
Robert P. Sheridan
Robert P. Sheridan MSD (United States)
Frederic D. Bushman
Frederic D. Bushman University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various interdisciplinary career pathways that go beyond traditional lab roles. For those interested in healthcare, becoming a functional medicine nurse practitioner salary specialist combines knowledge of biological sciences with patient-centered care, offering a rewarding, well-compensated career.

Alternatively, careers in healthcare administration and coding, such as a certified professional coder, are quickly growing fields that value scientific literacy and attention to detail, with flexible online programs available for certification.

For students or professionals facing unique challenges, such as having a criminal record, understanding the college degrees for felons can be crucial. Many online programs provide inclusive opportunities to pursue degrees in science and healthcare, helping individuals rebuild their careers.

Lastly, roles such as a child life specialist salary highlight career options that blend psychology, education, and biology, supporting children through medical experiences. These diverse pathways show how microbiology can be a foundation for meaningful careers in multiple sectors.

Best Scientists Citing Michael D. Miller

Recently Published Articles